Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Jul 23, 2019 2:34am

94 Views

Post# 29949477

RE:RE:RE:RE:RE:RE:interest in TH

Bucknelly21 - (7/22/2019 4:51:26 PM)
RE:RE:RE:RE:RE:interest in TH

I have confirmation that they are going to nasdaq as fast as possible

???
At these prices??? Then it shows they are desperate...........I for one hope they wait for some "things" to happen first and when the SP crawls higher they can file !!!
Going to nasdaq now means a massive dilution for existing shareholders!!
Why not wait for all those positives to come ( like SPCEO, jfm e o say) and file after that??

Bullboard Posts

AtkinsRéalis supports Poland’s nuclear power endeavour